Abstract:Three-dimensional (3-D) open-channeled scaffolds of biopolymers are a promising candidate matrix for tissue engineering. When scaffolds have the capacity to deliver bioactive molecules the potential for tissue regeneration should be greatly enhanced. In order to improve drug-delivery capacity, we exploit 3-D poly(lactic acid) (PLA) scaffolds by creating microporosity within the scaffold network. Macroporous channeled PLA with a controlled pore configuration was obtained by a robotic dispensing technique. In particular, a room temperature ionic liquid (RTIL) bearing hydrophilic counter-anions, such as OTf and Cl, was introduced to the biopolymer solution at varying ratios. The RTIL-biopolymer slurry was homogenized by ultrasonication, and then solidified through the robotic dispensing process, during which the biopolymer and RTIL formed a bicontinuous interpenetrating network. After ethanol wash-out treatment the RTIL was completely removed to leave highly microporous open channels throughout the PLA network. The resultant pore size was observed to be a few micrometers (average 2.43 μm) and microporosity was determined to be ∼ 70%. The microporous surface was also shown to favor initial cell adhesion, stimulating cell anchorage on the microporous structure. Furthermore, in vivo tissue responses assessed in rat subcutaneous tissue revealed good tissue compatibility, with minimal inflammatory reactions, while gathering a larger population of fibroblastic cells than the non-microporous scaffolds, and even facilitating invasion of the cells within the microporous structure. The efficacy of the micropore networks generated within the 3-D scaffolds in loading and releasing therapeutic molecules was addressed using antibiotic sodium ampicillin and protein cytochrome C as model drugs. The microporous scaffolds exhibited significantly enhanced drug loading capacity: 4-5 times increase in ampicillin and 9-10 times increase in cytochrome C compared to the non-microporous scaffolds. The release of ampicillin loaded within the microporous scaffolds was initially fast (∼ 85% for 1 week), and was then slowed down, showing a continual release up to a month. On the other hand, cytochrome C was shown to release in a highly sustainable manner over a month, without showing an initial burst release effect. This study provides a novel insight into the generation of 3-D biopolymer scaffolds with high performance in loading and delivery of biomolecules, facilitated by the creation of microporous channels through the scaffold network. The capacity to support tissue cells while in situ delivering drug molecules makes the current scaffolds potentially useful for therapeutic tissue engineering.

Nano-fibrous Scaffold for Controlled Delivery of Recombinant Human PDGF-BB.

Platelet-Derived Growth Factor Delivery Via Nanofibrous Scaffolds for Soft-Tissue Repair.

Nanofibrous Scaffolds Incorporating Pdgf-Bb Microspheres Induce Chemokine Expression And Tissue Neogenesis In Vivo

Nano-fibrous Tissue Engineering Scaffolds Capable of Growth Factor Delivery.

Sustained Pdgf-Bb Release from Phbhhx Loaded Nanoparticles in 3d Hydrogel/Stem Cell Model

The Enhancement of Osteogenesis by Nano-Fibrous Scaffolds Incorporating Rhbmp-7 Nanospheres.

Platelet-derived Growth Factor BB Gene-Released Scaffolds: Biosynthesis and Characterization

New Biodegradable Implant Material Containing Hydrogel with Growth Factors of Lyophilized PRF in Combination with an nHA/PLGA Scaffold

Dual Delivery for Stem Cell Differentiation Using Dexamethasone and Bfgf In/on Polymeric Microspheres As a Cell Carrier for Nucleus Pulposus Regeneration

Porous Nano-Ha/collagen/plla Scaffold Containing Chitosan Microspheres for Controlled Delivery of Synthetic Peptide Derived from BMP-2.

Incorporation of polymer microspheres within fibrin scaffolds for the controlled delivery of FGF-1

Tissue Engineering Scaffolds for Controlled Protein and Plasmid Delivery

Therapeutic foam scaffolds incorporating biopolymer-shelled mesoporous nanospheres with growth factors

Surface-engineering of Glycidyl Methacrylated Dextran/gelatin Microcapsules with Thermo-Responsive Poly(n-Isopropylacrylamide) Gates for Controlled Delivery of Stromal Cell-Derived Factor-1Α.

Novel Gene-Activated Matrix with Embedded Chitosan/plasmid DNA Nanoparticles Encoding PDGF for Periodontal Tissue Engineering.

A novel therapeutic design of microporous-structured biopolymer scaffolds for drug loading and delivery

Nanofibrous 3D Scaffolds Capable of Individually Controlled BMP and FGF Release for the Regulation of Bone Regeneration

In vitro and in vivo evaluation of a novel collagen/cellulose nanocrystals scaffold for achieving the sustained release of basic fibroblast growth factor

Precise Engineering of Growth Factor Presentation Using Extracellular Microenvironment-Mimicking Microfluidic Microparticles

Hierarchical Nanofibrous Microspheres with Controlled Growth Factor Delivery for Bone Regeneration

Controlled release of basic fibroblast growth factor from a peptide biomaterial for bone regeneration